Zacks Investment Research

Recent Articles

Nvidia (NVDA) Stock Gains as Rumors of Gaming GPU Launch Heat Up

By

Shares of Nvidia (NVDA) gained about 2.3% on Thursday as rumors of the company’s upcoming gaming GPU launch continue to heat up. Compare Brokers....

5 Successful New ETFs of Q2

By

Inside the most successful ETFs launched in the second quarter. Compare Brokers....

U.S. IPO Market Stages Solid Comeback: ETFs to Bet On

By

The U.S. IPO market recorded the highest activity volume in the first six months of the year since 2014 and the fourth-busiest year-to-date period since 1995. C....

Should You Buy Nvidia (NVDA) Stock Right Now?

By

Shares Nvidia (NVDA) surged 2.49% Thursday on the back of continued speculation that the chipmaker will release the much-anticipated update to its GeForce GPU l....

Chemical Production on the Upswing: 5 Growth Stocks to Buy

By

As the chemical industry’s upturn is expected to continue, it will be a prudent idea to zero in on these stocks with compelling growth prospects. Compare....

Buy These 3 Small-Cap Value Mutual Funds for Alluring Gains

By

Below we share with you three top-ranked, small-cap value mutual funds. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) Compare Brokers....

Facebook (FB) Stock Climbed Again Thursday: Time to Buy?

By

Shares of Facebook (FB) climbed over 2.5% on Thursday on the back of a massive new price target as well as some important news regarding its live video push. So....

5 of the Best Stocks Under $10 for 2018

By

Today we’ve highlighted five stocks that are currently trading for under $10 per share. All of these stocks currently sport a Zacks Rank #2 (Buy) or bette....

Duke Energy (DUK) to Pass on $142M in Tax Savings to Customers

By

Duke Energy (DUK) to pass on the $142 million tax cut benefits from the Tax Cuts and Jobs Act to its Indiana customers through rate savings. Compare Brokers....

4 Drug and Biotech Stocks Awaiting FDA Decisions in July

By

In the first six months of the year, the FDA grants approval to 17 new treatments. Compare Brokers....

Load More